<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
    <title>Progressive Health Blog</title>
    <link rel="alternate" type="text/html" href="http://blog.progressivehealth.com/" />
    <link rel="self" type="application/atom+xml" href="http://blog.progressivehealth.com/atom.xml" />
    <id>tag:blog.progressivehealth.com,2009-08-23://1</id>
    <updated>2008-11-19T12:10:37Z</updated>
    <subtitle>Ask industry experts questions about health conditions and what treatments are available. We cover a variety of topics describing how supplements can improve health conditions, what drugs interact with which supplements, and ongoing support for those who need help managing their health conditions. </subtitle>
    <generator uri="http://www.sixapart.com/movabletype/">Movable Type 4.31-en</generator>

<entry>
    <title>Omega 3 Essential Oils and Dry Eye</title>
    <link rel="alternate" type="text/html" href="http://blog.progressivehealth.com/omega_3_essential_oils_and_dry.html" />
    <id>tag:www.supplementnews.org,2006:/blog//1.351</id>

    <published>2010-08-31T17:00:00Z</published>
    <updated>2008-11-19T12:10:37Z</updated>

    <summary>A cohort study within the Women&apos;s Health Study examined the relationship (if any) between essential fatty acids and dry eye syndrome.  The results of the study were published in the October issue of American Journal of Clinical Nutrition (2005).</summary>
    <author>
        <name>Kris Foster</name>
        
    </author>
    
        <category term="Eye/Ocular Health" scheme="http://www.sixapart.com/ns/types#category" />
    
        <category term="Women&apos;s Health" scheme="http://www.sixapart.com/ns/types#category" />
    
    
    <content type="html" xml:lang="en" xml:base="http://blog.progressivehealth.com/">
        <![CDATA[<p>Dry eye syndrome, or sicca, is an inflammatory condition that may be mediated by autoimmune mechanisms.  It results in loss of normal tear and hydration solution production by the eye.  It is a relatively common condition that affects mainly women.  There is not an abundance of information concerning risks and protective factors against the development of dry eye syndrome.</p>

<p>One of the largest health studies to date, the Women's Health Study enrolled over 30,000 women to study various relationships between dietary and nutrient factors and disease.  A cohort study within the Women's Health Study examined the relationship (if any) between essential fatty acids and dry eye syndrome.  The results of the study were published in the October issue of American Journal of Clinical Nutrition (2005).</p>

<p>The cohort study involved 32,470 women from the Women's Health Study.  Out of these 4.7% had dry eye syndrome diagnosed by self report and clinical symptoms.  Fatty acid intake was assessed using food frequency questionnaires.  Relative intakes of omega three and omega six fatty acids were analyzed and compared to incidence of dry eye syndrome.</p>

<p>The study found that a higher ratio of omega 6 to omega 3 fatty acids increases the risk of developing dry eye syndrome.  A high intake of omega 3 fatty acids was associated with a lower risk, and specifically intake of tuna was inversely associated with dry eye syndrome.</p>

<p>The results of this study supports the previously held belief that omega 3 fatty acids are anti-inflammatory and may modulate autoimmune disease.  There is still some question about the overlap between autoimmune disease and inflammation.  Foods higher in omega 3 fatty acids such as fish, flax, and seeds may decrease ones risk for developing dry eye syndrome.  This can also be balanced by eating foods high in omega 6 fatty acids less often, namely animal meats.</p>]]>
        
    </content>
</entry>

<entry>
    <title>Natural Menopause Relief </title>
    <link rel="alternate" type="text/html" href="http://blog.progressivehealth.com/natural_menopause_relief.html" />
    <id>tag:blog.progressivehealth.com,2010://1.1739</id>

    <published>2010-08-29T19:56:33Z</published>
    <updated>2010-08-29T20:02:06Z</updated>

    <summary>The Peruvian plant maca (Lepidium meyenii) was used by the ancient Incans to increase libido and improve stamina. Maca has been found to have favorable antioxidant, antimicrobial and sexual function effects. Now research reports that maca can help relieve menopausal symptoms like hot flashes, low sex drive and night sweats. This discovery may provide a hormone-free alternative for managing menopause symptoms. The study, published in the International Journal of Biomedical Science, investigated the effect of...</summary>
    <author>
        <name>Elaine Gavalas</name>
        <uri>http://www.elainegavalas.com/</uri>
    </author>
    
        <category term="Women&apos;s Health" scheme="http://www.sixapart.com/ns/types#category" />
    
    
    <content type="html" xml:lang="en" xml:base="http://blog.progressivehealth.com/">
        <![CDATA[<img alt="iStock_000000317652XSmall.jpg" src="http://blog.progressivehealth.com/iStock_000000317652XSmall.jpg" width="208" height="318" class="mt-image-left" style="float: left; margin: 0 20px 20px 0;" /><p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial"><span style="letter-spacing: 0.0px">The Peruvian plant maca (Lepidium meyenii) was used by the ancient Incans to increase libido and improve stamina. Maca has been found to have favorable antioxidant, antimicrobial and sexual function effects. Now research reports that maca can help relieve menopausal symptoms like hot flashes, low sex drive and night sweats. This discovery may provide a hormone-free alternative for managing menopause symptoms.</span></p>
<p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial; min-height: 14.0px"><span style="letter-spacing: 0.0px"></span><br /></p>
<p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial"><span style="letter-spacing: 0.0px">The study, published in the <i><a href="http://ijbs.org/User/ContentFullText.aspx?VolumeNO=2&amp;StartPage=360"><b>International Journal of Biomedical Science</b></a></i>, investigated the effect of maca on menopausal symptoms. Australian and Polish researchers administered 2000 mg organic maca or a placebo daily to 124 postmenopausal women with low estrogen and high follicle stimulating hormone (FSH) levels for four months. Greene's Score (GMS) and Kupperman's Index (KMI) measurements of menopausal symptoms were obtained from the participants. Lipid profile and hormone levels were also obtained from the participants.</span></p>
<p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial; min-height: 14.0px"><span style="letter-spacing: 0.0px"></span><br /></p>
<p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial"><span style="letter-spacing: 0.0px">The researchers found that maca group had significant improvement in menopausal symptoms including hot flashes and night sweats. Furthermore, FSH levels were lowered while estradiol and 'good' HDL cholesterol levels were increased. The placebo group had no significant changes.&nbsp;</span></p>
<p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial; min-height: 14.0px"><span style="letter-spacing: 0.0px"></span><br /></p>
<p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial"><span style="letter-spacing: 0.0px">"Maca-GO [organic maca] significantly reduced both frequency and severity of individual menopausal symptoms (hot flushes and night sweating in particular) resulting in significant (P&lt;0.001) alleviation of KMI (from 22 to 10), thus, offering an attractive non-hormonal addition to the choices available to early-postmenopausal women in the form of a natural plant alternative to Hormone Replacement Therapy (HRT) - hence, reducing dependence on hormone therapy programs," the study authors conclude.&nbsp;</span></p>
<p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial; min-height: 14.0px"><span style="letter-spacing: 0.0px"></span><br /></p>
<p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial"><span style="letter-spacing: 0.0px">Balance Point for Women Enhances Wellness&nbsp;</span></p>
<p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial; color: #333333; min-height: 14.0px"><span style="letter-spacing: 0.0px"></span><br /></p>
<p style="margin: 0.0px 0.0px 0.0px 0.0px; line-height: 12.0px; font: 12.0px Arial"><span style="letter-spacing: 0.0px">Progressive Health's Balance Point for Women is a comprehensive <a href="http://www.progressivehealth.com/catalog/Balance_Point_for_Women.htm">multivitamin formula specially designed to support women's health.</a> It features 40 nutrients including vitamins (such as vitamin D), hormone helpers, antioxidant protectors, bone protectors, skin, hair and nail builders, and vision helpers.</span></p>
<p style="margin: 0.0px 0.0px 0.0px 0.0px; line-height: 12.0px; font: 12.0px Arial; min-height: 14.0px"><span style="letter-spacing: 0.0px"></span><br /></p>
<p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial Rounded MT Bold; color: #000099"><span class="Apple-style-span" style="color: rgb(51, 51, 51); font-family: Arial, helvetica, hirakakupro-w3, osaka, 'ms pgothic', sans-serif; ">Your Thoughts</span></p>
<p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial; min-height: 14.0px"><span style="letter-spacing: 0.0px"></span><br /></p>
<p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial"><span style="letter-spacing: 0.0px">Are you taking supplements to manage menopause symptoms? We'd love to hear about it! Please share with us below.</span></p><div><font class="Apple-style-span" size="3"><span class="Apple-style-span" style="font-size: 12px;"><br /></span></font></div> ]]>
        
    </content>
</entry>

<entry>
    <title>Warning: Prenatal Pesticide Exposure Linked to ADHD</title>
    <link rel="alternate" type="text/html" href="http://blog.progressivehealth.com/adhd_linked_to_prenatal_pesticide_exposure.html" />
    <id>tag:blog.progressivehealth.com,2010://1.1737</id>

    <published>2010-08-22T19:19:35Z</published>
    <updated>2010-08-22T19:25:04Z</updated>

    <summary><![CDATA[Organophosphate pesticides are used on conventionally grown fruits and vegetables.&nbsp;Previous studies suggests that organophosphate pesticides may be linked to attention-deficit hyperactivity disorder (ADHD). Now research reports that children's ADHD risk may be associated with pesticide exposure before birth. This suggests that pesticides may affect a fetus' developing nervous system.&nbsp; The study, published in Environmental Health Perspectives, examined the association&nbsp;between pesticide exposure during pregnancy and ADHD in children. Researchers at University of California Berkeley's Center for...]]></summary>
    <author>
        <name>Elaine Gavalas</name>
        <uri>http://www.elainegavalas.com/</uri>
    </author>
    
        <category term="Children&apos;s Health" scheme="http://www.sixapart.com/ns/types#category" />
    
        <category term="Women&apos;s Health" scheme="http://www.sixapart.com/ns/types#category" />
    
    
    <content type="html" xml:lang="en" xml:base="http://blog.progressivehealth.com/">
        <![CDATA[<img alt="iStock_000004358631XSmall.jpg" src="http://blog.progressivehealth.com/iStock_000004358631XSmall.jpg" width="319" height="212" class="mt-image-left" style="float: left; margin: 0 20px 20px 0;" /><p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial"><span style="letter-spacing: 0.0px">Organophosphate pesticides are used on conventionally grown fruits and vegetables.&nbsp;Previous studies suggests that organophosphate pesticides may be linked to attention-deficit hyperactivity disorder (ADHD). Now research reports that children's ADHD risk may be associated with pesticide exposure before birth. This suggests that pesticides may affect a fetus' developing nervous system.&nbsp;</span></p>
<p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial; min-height: 14.0px"><span style="letter-spacing: 0.0px"></span><br /></p>
<p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial"><span style="letter-spacing: 0.0px">The study, published in <i><a href="http://ehp03.niehs.nih.gov/article/info:doi/10.1289/ehp.1002056"><b>Environmental Health Perspectives</b></a></i>, examined the association&nbsp;between pesticide exposure during pregnancy and ADHD in children. Researchers at University of California Berkeley's Center for Children's Environmental Health analyzed data of 348 Mexican-American pregnant women and their children living in California Salinas Valley agricultural community. Urine samples were obtained from the pregnant women and tested for pesticide residue. ADHD questionnaires and tests were obtained from the children born to the pregnant women at ages 3 1/2 and 5.</span></p>
<p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial; min-height: 14.0px"><span style="letter-spacing: 0.0px"></span><br /></p>
<p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial"><span style="letter-spacing: 0.0px">The researchers found the highest association between pesticides and ADHD among the 5 year olds. Furthermore, ADHD risk increased with the highest levels of pesticide residue in women's urine. The risk of ADHD increased 5 times in children for every 10 time increase in women's pesticide residue.&nbsp;</span></p>
<p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial; color: #303030; min-height: 14.0px"><span style="letter-spacing: 0.0px"></span><br /></p>
<p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial"><span style="letter-spacing: 0.0px">"In utero DAPs [dialkyl phosphate] were associated adversely with attention in young children as assessed by maternal report, psychometrician observation, and direct assessment," the study authors write. "These associations were more robust at 5 than 3½ years and stronger in boys."</span></p>
<p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial; min-height: 14.0px"><span style="letter-spacing: 0.0px"></span><br /></p>
<p style="margin: 0.0px 0.0px 16.0px 0.0px; font: 12.0px Arial"><span style="letter-spacing: 0.0px">Naturally Relieve ADHD with Listol</span></p>
<p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial"><span style="letter-spacing: 0.0px">Progressive Health's Listol is a natural <a href="http://www.progressivehealth.com/catalog/Listol.htm">ADHD remedy</a> containing clinically evaluated ingredients such as phosphatidylserine, glycine, GABA, DMAE, Huperzine A and essential vitamins and minerals. Listol works to restore nutrient deficiencies associated with ADHD, relieve ADHD symptoms, and promote mental performance and brain health. &nbsp;</span></p>
<p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial; min-height: 14.0px"><span style="letter-spacing: 0.0px"></span><br /></p>
<p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial"><span style="letter-spacing: 0.0px">Your Thoughts</span></p>
<p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial; min-height: 14.0px"><span style="letter-spacing: 0.0px"></span><br /></p>
<p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial"><span style="letter-spacing: 0.0px">Is your child using alternative therapies to manage ADHD? Care to comment? Please share with us below.&nbsp;</span></p><div><font class="Apple-style-span" size="3"><span class="Apple-style-span" style="font-size: 12px; "><br /></span></font></div> ]]>
        
    </content>
</entry>

<entry>
    <title>Lactobacillus Possesses Anti-Candidal Activities</title>
    <link rel="alternate" type="text/html" href="http://blog.progressivehealth.com/lactobacillus_possesses_antica.html" />
    <id>tag:www.supplementnews.org,2006:/blog//1.341</id>

    <published>2010-08-17T17:00:00Z</published>
    <updated>2008-11-19T12:10:37Z</updated>

    <summary>Researchers in Poland published a study in June 2005 that measured the in vitro effects of lactobacillus against activity of Candida species.</summary>
    <author>
        <name>Kris Foster</name>
        
    </author>
    
        <category term="Dietary Supplements" scheme="http://www.sixapart.com/ns/types#category" />
    
        <category term="Women&apos;s Health" scheme="http://www.sixapart.com/ns/types#category" />
    
    
    <content type="html" xml:lang="en" xml:base="http://blog.progressivehealth.com/">
        <![CDATA[<p>Vaginal flora of healthy women is comprised of lactobacillus, yeast, group b strep, and several other non-pathological microorganisms that cause no disease or symptoms.  The primary organism is lactobacillus, which keeps the other organisms growth in check.  Studies have shown that lactobacillus protects against the development of bacterial vaginosis (BV) and urinary tract infections (UTI).  No current research exists that documents the effect lactobacillus has on vaginal Candida growth.  However, current belief is that lactobacillus can also prevent and treat vaginal Candida infections.</p>

<p>Researchers in Poland published a study in June 2005 that measured the in vitro effects of lactobacillus against activity of Candida species.  The study was aimed at determining the relationship between the two organisms as well as proving the effectiveness of lactobacillus to prevent vaginal candidiasis.  The mechanism of action was also investigated.  </p>

<p>Investigators measured the cell adhesion properties of lactobacillus.  Production of hydrogen peroxide (H2O2) by lactobacillus was also measured.  (Candida species are sensitive to H202.)  </p>

<p>The study showed that several strains of lactobacillus had high cell adhesion properties and prohibited the growth of Candida albicans, but not Candida pseudotropicalis.  Candida ablican is the most common organism responsible for yeast infections.  The mechanism of action in these lactobacillus strains was due in part to H2O2 production, but an alternative mechanism was suggested for two reasons.  First, catalase, which inhibits H2O2 production, did not decrease effectiveness.  And second, Candida strains were tested for resistance to H2O2 and found very resistant. </p>

<p>The investigators conclude that lactobacillus is effective at limiting growth of Candida. It may be a possible treatment alternative as well as prophylaxis.  The mechanism is due in part to H202, but some other role is in effect.  Further in vivo studies are needed to determine the true efficacy for treatment of vaginal Candida.</p>]]>
        
    </content>
</entry>

<entry>
    <title>Homeopathy for Postpartum Blood Loss?</title>
    <link rel="alternate" type="text/html" href="http://blog.progressivehealth.com/homeopathy_for_postpartum_bloo.html" />
    <id>tag:www.supplementnews.org,2006:/blog//1.340</id>

    <published>2010-08-16T17:00:00Z</published>
    <updated>2008-11-19T12:10:37Z</updated>

    <summary>Researchers in Israel tested the efficacy of Arnica Montana and Bellis perennis at halting blood loss after childbirth in a double-blind, randomized, placebo-controlled study.</summary>
    <author>
        <name>Kris Foster</name>
        
    </author>
    
        <category term="Women&apos;s Health" scheme="http://www.sixapart.com/ns/types#category" />
    
    
    <content type="html" xml:lang="en" xml:base="http://blog.progressivehealth.com/">
        <![CDATA[<p>The use of homeopathy has been apparent for centuries.  However, in modern medicine, the use of homeopathic remedies has been touted as placebo.  This fact is due to the inability of scientific, double-blind, placebo-controlled trials to show any difference between the effects of the remedy versus placebo.  </p>

<p>Homeopathic remedies are very dilute substances administered in specific cases.  The main action of the medicine is meant to be energetic, as no measurable substance is contained in the most potent forms.  Homeopathic remedies can be of any substance known to man, including plant, mineral, animal, light, and liquid.  </p>

<p>Researchers in Israel tested the efficacy of Arnica Montana and Bellis perennis at halting blood loss after childbirth in a double-blind, randomized, placebo-controlled study.  A total of 40 women enrolled in the study.  They were randomized to 3 groups, Arnica C6/BellisC6, Arnica C30/BellisC30, and double placebo.  Arnica and its placebo were discontinued after 48 hours while Bellis was continued until cessation of postpartum bleeding.  This is per their specific indications according to homeopathic materia medica.  The only outcome measure was total hemoglobin (Hb) at 48 and 72 hours post delivery.  </p>

<p>The results showed that individuals in the treatment group had higher Hb levels at 48 hours and 72 hours compared to placebo.  There was a significant increase in Hb levels from 48 to 72 hours in the treatment group, while the placebo group had a decrease in Hb levels from 48 to 72 hours.  Differences between the two groups were statistically significant.  Confounding variables were accounted for including Hb level at baseline (pre-delivery).  </p>

<p>The results are preliminary, and further analysis is being carried out.  However, they do show that Arnica Montana and Bellis perennis homeopathic remedies may decrease the amount of bleeding postpartum.</p>]]>
        
    </content>
</entry>

<entry>
    <title>Vegan Diet for Weight Loss in Women?</title>
    <link rel="alternate" type="text/html" href="http://blog.progressivehealth.com/vegan_diet_for_weight_loss_in.html" />
    <id>tag:www.supplementnews.org,2006:/blog//1.337</id>

    <published>2010-08-13T17:00:00Z</published>
    <updated>2008-11-19T12:10:37Z</updated>

    <summary>A recent study from the George Washington School of Medicine in Washington DC compared the effects of a vegan diet to the nationally recommended diet for cholesterol control.  The study participants were all overweight postmenopausal women.</summary>
    <author>
        <name>Kris Foster</name>
        
    </author>
    
        <category term="Women&apos;s Health" scheme="http://www.sixapart.com/ns/types#category" />
    
    
    <content type="html" xml:lang="en" xml:base="http://blog.progressivehealth.com/">
        <![CDATA[<p>The weight loss industry is skyrocketing in the United States as well as other countries in the world.  Many dietary supplements have made headlines recently highlighting claims for quick easy weight loss, only to later produce undesired side effects.  Researchers have changed focus to find easy alternatives for weight loss that focus on diet and lifestyle habits, with less a chance for adverse events.</p>

<p>A recent study from the George Washington School of Medicine in Washington DC compared the effects of a vegan diet to the nationally recommended diet for cholesterol control.  The study participants were all overweight postmenopausal women.  A total of 64 women completed the 14 week month double blind randomized placebo controlled trial.</p>

<p>In the trial women in the treatment group were assigned a low fat, plant based vegan diet free from dairy, eggs, and any animal protein.  The control group was given dietary guidelines outlined in the National Cholesterol Education Program.  There was no limit on the calorie intake.  Women were asked not to modify their current exercise program at admission to the study.</p>

<p>The primary outcomes included dietary intake, weight, and body composition, resting metabolic rate, insulin sensitivity, and thermic effect of food.  Measurements were taken at baseline and 14 weeks in all participants.</p>

<p>The researchers found that weight loss was significantly higher in the vegan diet group compared to the control group.  This was not affected by caloric intake, which did not differ between the two groups.  Weight change was found to be most effected by particular diet type, thermic effect of food, and resting metabolic rate.  There was a slight increase in insulin sensitivity in the treatment group, though insignificant when compared to the control.  </p>

<p>The authors concluded that a low fat, plant-based vegan diet can result in increased weight loss in postmenopausal overweight women compared to a nationally prescribed diet for weight loss that included animal proteins.  The weight loss was not associated with a decrease in caloric intake, but more so in the thermal effect of food and resting metabolic rate.</p>]]>
        
    </content>
</entry>

<entry>
    <title>Nutritional Status and Bone Density</title>
    <link rel="alternate" type="text/html" href="http://blog.progressivehealth.com/nutritional_status_and_bone_de.html" />
    <id>tag:www.supplementnews.org,2006:/blog//1.335</id>

    <published>2010-08-11T17:00:00Z</published>
    <updated>2008-11-19T12:10:37Z</updated>

    <summary>Researchers investigated a possible association between bone mineral density and antioxidant and mineral status in the Women&apos;s Health Initiative Study.</summary>
    <author>
        <name>Kris Foster</name>
        
    </author>
    
        <category term="Conditions of the Bone" scheme="http://www.sixapart.com/ns/types#category" />
    
        <category term="Women&apos;s Health" scheme="http://www.sixapart.com/ns/types#category" />
    
    
    <content type="html" xml:lang="en" xml:base="http://blog.progressivehealth.com/">
        <![CDATA[<p>Bone mineral density naturally declines with age.  However specific populations are at greater risk for developing osteoporosis, a severe loss of bone mineral density.  Osteoporosis increases the risk of fracture and hospitalization, both of which decrease the quality of life and contribute to morbidity.  </p>

<p>Natural decline in bone mineral density is thought to be affected by oxidative stress.  Antioxidant minerals and vitamins such as selenium, vitamin A, vitamin E, and vitamin C can reduce the amount of oxidative stress in the body.  Researchers investigated a possible association between bone mineral density and antioxidant and mineral status in the Women's Health Initiative Study.</p>

<p>The results were published this September in the American Journal of Clinical Nutrition.  A total of 11, 068 women participated in the study that measured bone mineral density, dietary intake of antioxidants (A, C, E, selenium, and beta carotene), antioxidant supplement use.  A smaller subset of women had serum concentrations of carotenoids, retinoids, and tocopherols measured and used in analysis.  </p>

<p>They found that antioxidant intake was not independently related to bone mineral density.  Increased or decreased intake of Vitamins A, C, E, beta-carotene, or selenium was not associated with any changes in bone mineral density.  One interaction, statistically significant, was found in women who used hormone replacement.  The analysis showed that Vitamin C intake and hormone therapy was associated with a greater bone mineral density in the femoral neck, total body, and spine.  </p>

<p>The authors conclude that antioxidant vitamin and mineral intake is not an independent therapeutic marker for bone mineral density.  However, a significant relationship was found between Vitamin C and bone mineral density in a subset of women who were taking hormone replacement therapy (HRT).  The authors state that this relationship needs to be explored further in order to offer therapeutic recommendations.</p>]]>
        
    </content>
</entry>

<entry>
    <title>Preventing Bone Loss with Vitamin D3</title>
    <link rel="alternate" type="text/html" href="http://blog.progressivehealth.com/preventing_bone_loss_with_vita.html" />
    <id>tag:www.supplementnews.org,2006:/blog//1.330</id>

    <published>2010-08-03T17:00:00Z</published>
    <updated>2008-11-19T12:10:37Z</updated>

    <summary>Previous research has shown that calcium supplementation alone, and with Vitamin D, can improve bone mineral density in postmenopausal women.  A new study published in the Archives of Internal Medicine in July investigated the effect, if any, of Vitamin D3 supplementation in African American postmenopausal women who are receiving adequate calcium.</summary>
    <author>
        <name>Kris Foster</name>
        
    </author>
    
        <category term="Conditions of the Bone" scheme="http://www.sixapart.com/ns/types#category" />
    
        <category term="Women&apos;s Health" scheme="http://www.sixapart.com/ns/types#category" />
    
    
    <content type="html" xml:lang="en" xml:base="http://blog.progressivehealth.com/">
        <![CDATA[<p>Bone loss and development of osteoporosis in women after menopause is a common concern.  Estrogen is involved in bone metabolism in women, and as levels decline during menopause, bone mineral density declines.  Bone mineral density decreases due to calcium being absorbed from the bone into the blood.  This process can be exacerbated with low calcium intake and low Vitamin D status.  </p>

<p>Previous research has shown that calcium supplementation alone, and with Vitamin D, can improve bone mineral density in postmenopausal women.  A new study published in the Archives of Internal Medicine in July investigated the effect, if any, of Vitamin D3 supplementation in African American postmenopausal women who are receiving adequate calcium.  </p>

<p>The study enrolled 208 healthy postmenopausal women of African American background.  They were between the ages of 50 and 75 years old.  They were ensured a total calcium intake between 1200 and 1500mg/day.  The women were randomized to two groups; the treatment group received 20mcg/day (800 IU) of Vitamin D3, versus placebo.  After 2 years the amount of D3 was increased to 50mcg/day.  Bone mineral density was measured at 6 month intervals.  Other outcome measures included concentration of Vitamin d metabolites, parathyroid hormone, and markers of bone mineral turnover in the blood.</p>

<p>At completion of the study (3 years later) bone mineral density was compared between the two groups.  There were no statistical differences throughout the study.  The researcher also found no relationship between the rate of bone turnover and the levels of Vitamin D.  There was no difference in bone turnover markers, parathyroid hormone between the groups as well.  NO adverse effects were observed due to Vitamin D supplementation.</p>

<p>In conclusion, the addition of Vitamin D to the treatment regimen of postmenopausal African American women receiving adequate nutrition provided no additional health benefit.  No effect was observed on bone mineral density or markers of bone turnover.  Further studies are needed to determine if these results can be applied to women of other ethic backgrounds.  As a race, African American women tend to be less at risk for osteoporosis.  Caucasian and Asian women are at greater risk for developing the disease.</p>]]>
        
    </content>
</entry>

<entry>
    <title>Maternal Smoking Increases Attention Deficit Disorders</title>
    <link rel="alternate" type="text/html" href="http://blog.progressivehealth.com/maternal_smoking_increases_att.html" />
    <id>tag:www.supplementnews.org,2006:/blog//1.328</id>

    <published>2010-08-01T17:00:00Z</published>
    <updated>2008-11-19T12:10:37Z</updated>

    <summary>An investigative case-controlled study was published in Pediatrics in August 2005 that examined the effect that maternal smoking has on behavioral development and the incidence of hyperkinetic disorders. </summary>
    <author>
        <name>Kris Foster</name>
        
    </author>
    
        <category term="Children&apos;s Health" scheme="http://www.sixapart.com/ns/types#category" />
    
        <category term="Conditions of the Brain" scheme="http://www.sixapart.com/ns/types#category" />
    
        <category term="Women&apos;s Health" scheme="http://www.sixapart.com/ns/types#category" />
    
    
    <content type="html" xml:lang="en" xml:base="http://blog.progressivehealth.com/">
        <![CDATA[<p>It has been a recommendation that women who smoke cigarettes quit upon knowledge of pregnancy due to the increased neonatal morbidity and mortality associated with the habit.  Women who smoke during pregnancy are at increased risk for preterm delivery and low birth weight children.  It is believed that smoking cigarettes during pregnancy may also increase the risk for behavioral disorders.</p>

<p>An investigative case-controlled study was published in Pediatrics in August that examined the effect that maternal smoking has on behavioral development and the incidence of hyperkinetic disorders.  Hyperkinetic disorders include behavioral disorders such as ADHD. The primary characteristics include hyperactivity and poor social interaction.</p>

<p>The study obtained data from 3765 control children and 170 children with hyperkinetic disorders.  Factors such as newborn characteristics, socioeconomic status, and family history of psychiatric disease were accounted for during analysis.  Smoking history was obtained through interview or questionnaire.  </p>

<p>The research showed that infants born to mothers who smoked cigarettes had 3 times the chance of developing a hyperkinetic disorder such as ADHD compared to an infant with a non-smoking mother.  These results were not related to newborn characteristics, family history, or socioeconomic factors.  </p>

<p>This research supports the recommendation that women who smoke cigarettes should quit upon the knowing they have become pregnant.  Smoking increased neonatal morbidity and mortality and is now proven to affect behavioral development.</p>]]>
        
    </content>
</entry>

<entry>
    <title>Donor Milk vs. Formula for Preterm Infants</title>
    <link rel="alternate" type="text/html" href="http://blog.progressivehealth.com/donor_milk_vs_formula_for_pret.html" />
    <id>tag:www.supplementnews.org,2006:/blog//1.326</id>

    <published>2010-07-28T17:00:00Z</published>
    <updated>2008-11-19T12:10:37Z</updated>

    <summary>A study published in the Journal of Pediatrics in August compared the outcomes of preterm infants given mothers milk to those given donor milk or preterm formula.</summary>
    <author>
        <name>Kris Foster</name>
        
    </author>
    
        <category term="Children&apos;s Health" scheme="http://www.sixapart.com/ns/types#category" />
    
        <category term="Women&apos;s Health" scheme="http://www.sixapart.com/ns/types#category" />
    
    
    <content type="html" xml:lang="en" xml:base="http://blog.progressivehealth.com/">
        <![CDATA[<p>Infants that are born at less than 30 weeks gestation are at increased risk for infection, late onset sepsis (LOS), necrotizing enterocolitis (NEC), long term hospital stay, urinary tract infections and poor growth among other conditions.  Previous work has proven that mother's milk is superior to supplementation with formula designed specifically for preterm infants.  Infants born prematurely who are fed from mother's milk have lower rates of infection, LOS, and NEC compared to those given preterm formula.  They also have a decreased length of hospital stay.</p>

<p>A common problem that can occur with preterm delivery and hospital stay is insufficient production of milk by the mother.  In that case the current recommendation is supplementation of mother's milk with preterm formula.  A study published in the Journal of Pediatrics in August compared the outcomes of preterm infants given mothers milk to those given donor milk or preterm formula.</p>

<p>The study enrolled infants born at less than 30 weeks gestation.  A total of 243 infants were enrolled, 70 received only mother's milk.  The remaining infants were randomized to receive either pasteurized donors milk or preterm formula.  A total of 81 infants did the donors milk and 92 received preterm formulas.  The study was conducted from delivery to 90 days or hospital discharge, which ever is the lesser.  Outcome measures included rates of infection, hospital stay, growth, LOS, NEC, meningitis, urinary tract infection, and skin to skin contact.</p>

<p>The study showed that there were no differences between LOS, NEC, hospital stay, growth and rates of infection between the groups given donor's milk or preterm formula,  however infants given only mother's milk had lower rates of LOS, NEC and infection.  The group receiving donor's milk had a lower rate of growth, even though they received more food and nutritional supplementation on an average.  </p>

<p>The authors concluded that for preterm infants born before 30 weeks gestation donor milk offered little advantage over preterm formula with mothers milk could not be the sole source of nutrition.  Mother's milk is still the superior food source for preterm infants to insure proper growth and decreased rates of infection.</p>]]>
        
    </content>
</entry>

<entry>
    <title>Scientific Breakthrough: Vaginal Gel Reduces HIV Risk 40% </title>
    <link rel="alternate" type="text/html" href="http://blog.progressivehealth.com/scientific_breakthrough_vaginal_gel_reduces_hiv_risk_40.html" />
    <id>tag:blog.progressivehealth.com,2010://1.1713</id>

    <published>2010-07-20T16:49:56Z</published>
    <updated>2010-07-20T16:55:02Z</updated>

    <summary><![CDATA[For years researchers have been working to create an "invisible condom" for women to prevent HIV infection. Now research reports a scientific breakthrough with a vaginal gel that helps prevent HIV and herpes infections in women. The vaginal microbicide gel contains 1% tenofovir, an antiretroviral drug used in HIV treatment. Researchers estimate that the gel can reduce the risk of HIV infection by up to 40 percent, preventing millions of new HIV infections worldwide. The&nbsp;...]]></summary>
    <author>
        <name>Elaine Gavalas</name>
        <uri>http://www.elainegavalas.com/</uri>
    </author>
    
        <category term="Infectious Diseases" scheme="http://www.sixapart.com/ns/types#category" />
    
        <category term="Women&apos;s Health" scheme="http://www.sixapart.com/ns/types#category" />
    
    
    <content type="html" xml:lang="en" xml:base="http://blog.progressivehealth.com/">
        <![CDATA[<img alt="400px-Spinning_device.jpg" src="http://blog.progressivehealth.com/400px-Spinning_device.jpg" width="213" height="319" class="mt-image-left" style="float: left; margin: 0 20px 20px 0;" /><p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial"><span style="letter-spacing: 0.0px">For years researchers have been working to create an "invisible condom" for women to prevent HIV infection. Now research reports a scientific breakthrough with a vaginal gel that helps prevent HIV and herpes infections in women. The vaginal microbicide gel contains 1% tenofovir, an antiretroviral drug used in HIV treatment. Researchers estimate that the gel can reduce the risk of HIV infection by up to 40 percent, preventing millions of new HIV infections worldwide.</span></p>
<p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial; min-height: 14.0px"><span style="letter-spacing: 0.0px"></span><br /></p>
<p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial"><span style="letter-spacing: 0.0px">The&nbsp; double-blind placebo-controlled study, presented at the XVIII International AIDS Conference in Vienna, Austria<i>,</i> examined the effectiveness of tenofovir vaginal gel on women at high risk for HIV infection. Researchers at the Centre for the AIDS Programme of Research in South Africa (CAPRISA), administered tenofovir gel or a placebo to 889 sexually active and HIV-negative women (ages 18 to 40) living in urban and rural sites in South Africa. All of the women were counseled on application of the vaginal gel, safe sex and condom use.</span></p>
<p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial; min-height: 14.0px"><span style="letter-spacing: 0.0px"></span><br /></p>
<p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial"><span style="letter-spacing: 0.0px">&nbsp;The researchers found that the tenofovir group had a 39 percent decreased risk of HIV infection, compared to the placebo group. Furthermore, the tenofovir group had a 51 percent decreased risk of genital herpes infection. However, there was some evidence that the gel may become less effective over time. A larger study is currently underway.</span></p>
<p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial; min-height: 14.0px"><span style="letter-spacing: 0.0px"></span><br /></p>
<p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial"><span style="letter-spacing: 0.0px">"Tenofovir gel could fill an important HIV prevention gap by empowering women who are unable to successfully negotiate mutual faithfulness or condom use with their male partners," says researcher Dr. Quarraisha Abdool Karim, Associate Director of CAPRISA and Associate Professor of Epidemiology at Columbia University, in a <a href="http://eurekalert.org/pub_releases/2010-07/c-som071610.php">news release</a>. "This new technology has the potential to alter the course of the HIV epidemic, especially in southern Africa where young women bear the brunt of this devastating disease."</span></p>
<p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial; min-height: 14.0px"><span style="letter-spacing: 0.0px">&nbsp;</span></p>
<p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial"><span style="letter-spacing: 0.0px">Prenox D7 Boosts Immunity</span></p>
<p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial; min-height: 14.0px"><span style="letter-spacing: 0.0px"></span><br /></p>
<p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial"><span style="letter-spacing: 0.0px">Although there is no cure for AIDS (Acquired Immune Deficiency Syndrome),&nbsp;natural nutrients can promote immune health and nutritional support for AIDS and HIV infection.</span></p>
<p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial; min-height: 14.0px"><span style="letter-spacing: 0.0px"></span><br /></p>
<p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial"><span style="letter-spacing: 0.0px">Progressive Health's Prenox D7 works to <a href="http://www.progressivehealth.com/catalog/Prenox-D7.htm">restore lost nutrients, strengthen immunity and support overall health in AIDS patients</a>. Prenox D7 contains clinically evaluated nutrients including olive leaf extract, milk thistle, reishi mushroom, shitake mushroom, NAC (n-acetyl cysteine), beta sitoserol, carnitine, coenzyme Q10, betaine, l-glutamine and essential vitamins and minerals.</span></p>
<p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial; min-height: 14.0px"><span style="letter-spacing: 0.0px"></span><br /></p>
<p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial"><span style="letter-spacing: 0.0px">Your Thoughts</span></p>
<p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial; min-height: 14.0px"><span style="letter-spacing: 0.0px"></span><br /></p>
<p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial"><span style="letter-spacing: 0.0px">What do you think about this scientific breakthrough? Please share with us below.</span></p><div><font class="Apple-style-span" size="3"><span class="Apple-style-span" style="font-size: 12px; "><br /></span></font></div> ]]>
        
    </content>
</entry>

<entry>
    <title>Cimifuga Racemosa and Estradiol for Menopausal Complaints</title>
    <link rel="alternate" type="text/html" href="http://blog.progressivehealth.com/cimifuga_racemosa_and_estradio.html" />
    <id>tag:www.supplementnews.org,2006:/blog//1.316</id>

    <published>2010-07-16T17:00:00Z</published>
    <updated>2008-11-19T12:10:37Z</updated>

    <summary>Gynecology and Endocrinology published an article earlier this year that gives evidence of the usefulness of Cimicifuga racemosa (black cohosh) for treating climacteric complaints of menopause.</summary>
    <author>
        <name>Kris Foster</name>
        
    </author>
    
        <category term="Women&apos;s Health" scheme="http://www.sixapart.com/ns/types#category" />
    
    
    <content type="html" xml:lang="en" xml:base="http://blog.progressivehealth.com/">
        <![CDATA[<p>Conventional medicine uses hormonal therapy to treat the many complaints of menopause.  With recent evidence showing that long term hormonal therapy may increase risk of heart disease and cancer in post menopausal women, healthy effective alternatives are being sought.  Traditional botanical medicine has several therapies effective at treating menopausal complaints, but many have not been supported by clinical trials.  <em>Cimicifuga racemosa</em>, or as it more commonly known, black cohosh, is a well known and commonly used botanical with phytoestrogen activity.  It has been used for menopausal complaints for decades.</p>

<p>Gynecology and Endocrinology published an article earlier this year that gives evidence of the usefulness of <em>Cimicifuga racemosa</em> (black cohosh) for treating climacteric complaints of menopause.  The study was even more substantial because it compared the effects of black cohosh to low dose estradiol.</p>

<p>The study had 64 postmenopausal women participants.  They were randomized to receive 40mg of <em>Cimicifuga racemosa</em> or 25mcg of Estradiol.  They were also given 10mg Progesterone 2 weeks of the month to balance out the estrogen therapy.  The study lasted 3 months.  </p>

<p>During that time women recorded the number of hot flashes, as well as urogenital symptoms, vasomotor symptoms, and periods of anxiety and depression.  Lab values that were measured include LH, FSH, prolactin, cortisol, E2, HDL, LDL, and liver enzymes. </p>

<p>The results prove that both black cohosh and Estradiol are effective at decreasing the number of hot flashes by a significant amount; there was no significant difference between the two therapies.  Vasomotor symptoms, anxiety, and depression were also decreased by both <em>Cimicifuga </em>and estradiol.  Total cholesterol was decreased by estradiol and not <em>Cimicifuga</em>.  Both <em>Cimicifuga </em>and estradiol decreased LDL, while only the black cohosh increased HDL (which may explain why total cholesterol did not decrease in <em>Cimicifuga </em>group).  </p>

<p>As well, there was no change in liver enzymes, cortisol, FSH, and LH in either group, while Estradiol increased prolactin and E2.</p>]]>
        
    </content>
</entry>

<entry>
    <title>Is Low Dose DHA  Supplementation in Breastfeeding Mothers Helpful?</title>
    <link rel="alternate" type="text/html" href="http://blog.progressivehealth.com/is_low_dose_dha_supplementatio.html" />
    <id>tag:www.supplementnews.org,2006:/blog//1.313</id>

    <published>2010-07-13T17:00:00Z</published>
    <updated>2008-11-19T12:10:37Z</updated>

    <summary>The Journal of Clinical Nutrition published a follow-up study on women who supplemented with DHA for 4 months after delivery while breastfeeding.  Infants were tested at 4, 8, 12, and 30 months for brain and visual development and were compared to infants whose mothers did not supplement with DHA.</summary>
    <author>
        <name>Kris Foster</name>
        
    </author>
    
        <category term="Women&apos;s Health" scheme="http://www.sixapart.com/ns/types#category" />
    
    
    <content type="html" xml:lang="en" xml:base="http://blog.progressivehealth.com/">
        <![CDATA[<p>DHA is an essential fatty acid believed to be necessary for the development of visual and neurological function in infants.  Supplementation with DHA is commonly recommended to increase the visuals and brain development of newborns.  DHA can be supplanted by the mother to provide benefit to the newborn, and it is also added to some infant formulas to benefit infants whose mothers choose not to breastfeed.  To date there have not been any trials that have attempted to show positive effects on visual and brain development.  <br />
 	<br />
The Journal of Clinical Nutrition published a follow-up study on women who supplemented with DHA for 4 months after delivery while breastfeeding.  Infants were tested at 4, 8, 12, and 30 months for brain and visual development and were compared to infants whose mothers did not supplement with DHA. </p>

<p>DHA levels were measured in the milk and infant plasma after the supplementation period to insure absorption and transfer to the infants.  DHA was 75% higher in the breast milk of mother's who supplemented and was 35% higher in the infants of mothers who supplemented.  This represents substantial evidence that DHA supplementation does increase the levels available to infants.</p>

<p>However measurements of visuals and brains development did not reflect as dramatic of changes.  The researchers found no difference in visual development at 4 or 8 months and no difference in brain development at 12 months of age in infants whose mothers supplemented with DHA.  At 30 months infants whose mothers supplemented scored higher on the Bagley Psychomotor Developmental Index than non-supplemented mothers.</p>

<p>The results of this study should not lead one to conclude that there is no effect on visual and brain development from DHA.  The dose was only 200mg per day, which is lower than the average supplemented amount of 600mg-1200mg.  Further studies are needed to determine the effects of DHA.</p>]]>
        
    </content>
</entry>

<entry>
    <title>Early Puberty Linked to More Meat</title>
    <link rel="alternate" type="text/html" href="http://blog.progressivehealth.com/early_puberty_linked_to_more_meat.html" />
    <id>tag:blog.progressivehealth.com,2010://1.1709</id>

    <published>2010-07-13T16:04:29Z</published>
    <updated>2010-07-13T16:09:01Z</updated>

    <summary>Early puberty may be associated with obesity or exposure to artificial chemicals in food and plastic products that interfere with sexual development. Previous research suggests that early puberty may increase the risk of cancer and heart disease in adulthood. Now research reports that early puberty may be linked to more meat in children&apos;s diets. Worldwide, more girls have been reaching puberty before the age of 10. The study, published in Public Health Nutrition, investigated the...</summary>
    <author>
        <name>Elaine Gavalas</name>
        <uri>http://www.elainegavalas.com/</uri>
    </author>
    
        <category term="Children&apos;s Health" scheme="http://www.sixapart.com/ns/types#category" />
    
        <category term="Women&apos;s Health" scheme="http://www.sixapart.com/ns/types#category" />
    
    
    <content type="html" xml:lang="en" xml:base="http://blog.progressivehealth.com/">
        <![CDATA[<img alt="iStock_000012073096XSmall.jpg" src="http://blog.progressivehealth.com/iStock_000012073096XSmall.jpg" width="319" height="212" class="mt-image-left" style="float: left; margin: 0 20px 20px 0;" /><p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica"><span style="letter-spacing: 0.0px">Early puberty may be associated with obesity or exposure to artificial chemicals in food and plastic products that interfere with sexual development. Previous research suggests that early puberty may increase the risk of cancer and heart disease in adulthood. Now research reports that early puberty may be linked to more meat in children's diets. Worldwide, more girls have been reaching puberty before the age of 10.</span></p>
<p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial; min-height: 14.0px"><span style="letter-spacing: 0.0px"></span><br /></p>
<p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial"><span style="letter-spacing: 0.0px">The study, published in <i><a href="http://journals.cambridge.org/action/displayAbstract?fromPage=online&amp;aid=7798242&amp;fulltextType=RA&amp;fileId=S1368980010001461">Public Health Nutrition</a></i>, investigated the association between diet and age of menarche (menstruation onset). Researchers at the University of Brighton, UK analyzed data of 3298 girls at ages three and seven years, enrolled in the Avon Longitudinal Study of Parents and Children. Food frequency questionnaires and food diaries were obtained from the participants.&nbsp;</span></p>
<p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial; min-height: 14.0px"><span style="letter-spacing: 0.0px"></span><br /></p>
<p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial"><span style="letter-spacing: 0.0px">The researchers found 49 percent of girls eating meat more than 12 times per week at 7 years old had started their periods by age 12 1/2, compared with 35 percent of those eating meat less than four times a week. Furthermore, girls with the highest meat consumption at 3 and 7 years old were more likely to reach puberty by age 12.</span></p>
<p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial; min-height: 14.0px"><span style="letter-spacing: 0.0px"></span><br /></p>
<p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial"><p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial"><span style="letter-spacing: 0.0px">"These data suggest that higher intakes of protein and meat in early to mid-childhood may lead to earlier menarche," the study authors write. "This may have implications for the lifetime risk of breast cancer and osteoporosis."&nbsp;</span></p><div><br /></div><div>Promote Women's Health with Balance Point&nbsp;</div></p>
<p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial; color: #333333; min-height: 14.0px"><span style="letter-spacing: 0.0px"></span><br /></p>
<p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial"><span style="letter-spacing: 0.0px">Progressive Health's Balance Point for Women is a comprehensive <a href="http://www.progressivehealth.com/catalog/Balance_Point_for_Women.htm">multivitamin and nutrient formula specially designed to support women's health</a>. It features 40 nutrients including vitamins, minerals, hormone helpers, antioxidant protectors, bone protectors, skin, hair and nail builders, and vision helpers.</span></p>
<p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial; min-height: 14.0px"><span style="letter-spacing: 0.0px"></span><br /></p>
<p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial; color: #000099"><span class="Apple-style-span" style="color: rgb(51, 51, 51); ">Your Thoughts</span></p>
<p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial; color: #333333; min-height: 14.0px"><span style="letter-spacing: 0.0px"></span><br /></p>
<p style="margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial"><span style="letter-spacing: 0.0px">Are you taking positive action to help your child eat a healthy diet? Please share with us below.&nbsp;</span></p><div><font class="Apple-style-span" size="3"><span class="Apple-style-span" style="font-size: 12px;"><br /></span></font></div> ]]>
        
    </content>
</entry>

<entry>
    <title>Retinoic Acid&apos;s Effect on Former Smokers</title>
    <link rel="alternate" type="text/html" href="http://blog.progressivehealth.com/retinoic_acids_effect_on_forme.html" />
    <id>tag:www.supplementnews.org,2006:/blog//1.312</id>

    <published>2010-07-12T17:00:00Z</published>
    <updated>2008-11-19T12:10:37Z</updated>

    <summary>Recent research published in the Journal of Clinical Oncology investigated if 9-cis-retinoic acid has any effect on the IGF axis and if this could in fact be the mechanism of its chemopreventative effects against lung cancer.</summary>
    <author>
        <name>Kris Foster</name>
        
    </author>
    
        <category term="Conditions of the Respiratory System" scheme="http://www.sixapart.com/ns/types#category" />
    
        <category term="Men&apos;s Health" scheme="http://www.sixapart.com/ns/types#category" />
    
        <category term="Misc." scheme="http://www.sixapart.com/ns/types#category" />
    
        <category term="Women&apos;s Health" scheme="http://www.sixapart.com/ns/types#category" />
    
    
    <content type="html" xml:lang="en" xml:base="http://blog.progressivehealth.com/">
        <![CDATA[<p>Smokers are at increased risk for cancer, especially lung cancer.  One reason for this increased risk is the high level of oxidative damage from the contaminants in cigarette smoke.  However, lung cancer is the number 2 killer of women and the number 3 killer of men, even in non-smoking populations.  There are many other risk factors for lung cancer.  Among these is the Insulin Growth Factor axis (IGF).  </p>

<p>Antioxidant therapy has been associated with a decreased risk of lung cancer.  One class of potent antioxidants is the carotenes, or Vitamin A hormones.  9-cis-retinoic acid has been proven to be a potent antioxidant in former smokers, although its mechanism is not fully understood.  Recent research published in the Journal of Clinical Oncology investigated if 9-cis-retinoic acid has any effect on the IGF axis and if this could in fact be the mechanism of its chemopreventative effects against lung cancer.  </p>

<p>The study enrolled participants who had ceased smoking for at least 12 months.  IGF-I and IGF binding protein concentrations were measured at baseline and completion of the study in 111 and 84 participants respectively.  Participants received either 100mg of 9-cis-retinoic acid or placebo daily.  </p>

<p>The IGF-I and ratio of IGF-I/IGF binding protein were significantly lower in the treatment group compared to placebo.  However, the IGF binding protein increased in the treatment group.  </p>

<p>The authors conclude that 9-cis-retenoic acid modulates the IGF axis in former smokers.  This may be the mechanism for chemoprevention.  In the future serum concentrations of IGF axis components may be used as end markers for treatment.  More studies are needed to determine any correlation between 9-cis-retinoic acid treatment, IGF axis, and lung cancer risk.  In this study, no follow-up on lung cancer incidence was determined, thus it is inconclusive if any effect can be obtained by treatment with 9-cis-retinoic acid.</p>]]>
        
    </content>
</entry>

</feed>
